SOPHiA GENETICS SA
NASDAQ:SOPH
3.035 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 62.371 | 47.56 | 40.45 | 28.4 | 25.362 |
| Cost of Revenue
| 19.458 | 16.306 | 15.229 | 10.709 | 7.532 |
| Gross Profit
| 42.913 | 31.254 | 25.221 | 17.691 | 17.83 |
| Gross Profit Ratio
| 0.688 | 0.657 | 0.624 | 0.623 | 0.703 |
| Reseach & Development Expenses
| 36.969 | 35.371 | 26.578 | 18.588 | 15.018 |
| General & Administrative Expenses
| 53.301 | 55.816 | 41.505 | 18.965 | 15.669 |
| Selling & Marketing Expenses
| 28.423 | 28.267 | 28.735 | 17.432 | 19.414 |
| SG&A
| 81.724 | 84.083 | 70.24 | 36.397 | 35.083 |
| Other Expenses
| -0.954 | -0.377 | -0.108 | -0.129 | 0.016 |
| Operating Expenses
| 117.739 | 119.077 | 96.71 | 54.856 | 50.117 |
| Operating Income
| -74.826 | -87.823 | -71.489 | -37.165 | -32.287 |
| Operating Income Ratio
| -1.2 | -1.847 | -1.767 | -1.309 | -1.273 |
| Total Other Income Expenses Net
| -3.669 | 0.238 | -2.018 | -3.838 | -1.342 |
| Income Before Tax
| -78.495 | -87.585 | -73.507 | -41.225 | -33.629 |
| Income Before Tax Ratio
| -1.259 | -1.842 | -1.817 | -1.452 | -1.326 |
| Income Tax Expense
| 0.486 | -0.136 | 0.168 | -1.886 | 0.162 |
| Net Income
| -78.981 | -87.449 | -73.675 | -39.339 | -33.791 |
| Net Income Ratio
| -1.266 | -1.839 | -1.821 | -1.385 | -1.332 |
| EPS
| -1.22 | -1.36 | -1.15 | -0.62 | -0.53 |
| EPS Diluted
| -1.22 | -1.36 | -1.15 | -0.62 | -0.53 |
| EBITDA
| -70.7 | -82.667 | -70.837 | -38.758 | -30.741 |
| EBITDA Ratio
| -1.134 | -1.729 | -1.678 | -1.221 | -1.194 |